SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Arzneiverordnungs-Report 2011
0 references·2 citing·9 second hop
Arzneiverordnungs-Report 2011 (2011)Arzneiverordnungs-Report 2011Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases (2017)Budgetary Impact and Cost Dri…Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach (2012)Payers endorse generics to en…Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)European payer initiatives to reduce prescribing costs through use of generics (2012)Different initiatives across Europe to enhance losartan utilization post generics: impact and implications (2014)Pricing of oral generic cancer medicines in 25 European countries; findings and implications (2019)Systematic review and meta-analysis (2019)Eliciting public preferences for healthcare: a systematic review of techniques (2001)Social Value Orientation (2013)Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries (2015)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2012Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach60 cited
  • 2017Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases47 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work